Betablockers and clinical outcome after surgical aortic valve replacement: a report from the SWEDEHEART registry
Treatment with betablockers did not appear to be associated with inferior long-term outcome after SAVR, when adjusting for new concomitant diseases. Thus, it is likely that it is the underlying cardiac diseases that are associated with MACE rather than betablocker treatment.
Authors
- Charlotta Törngren
- Julia Baranowska (ORCID: https://orcid.org/0000-0002-8911-2708)
- Emma C. Hansson (ORCID: https://orcid.org/0000-0002-3083-0860)
- Andreas Martinsson (ORCID: https://orcid.org/0000-0003-1461-0777)
- Emily Pan (ORCID: https://orcid.org/0000-0001-9624-6539)
- Martin Karlsson (ORCID: https://orcid.org/0000-0002-1707-9398)
- Erik Björklund (ORCID: https://orcid.org/0000-0003-2831-3749)
Institutions
- University of Turku (FI)
- Sahlgrenska University Hospital (SE)
- Södra Älvsborg Hospital (SE)
- Central Finland Health Care District (FI)
- University of Gothenburg (SE)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/ejcts/ezae365
- Citations
- 2
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Hjärt-Lungfonden